Q4FY17 Results : Jubilant Life Sciences

Jubilant Life Sciences Ltd reported its results for the quarter ended March 31, 2017 today.

The company's total sales for Q4FY17 came in at Rs 1597.76 crore, which represents a 9.57 per cent sequential increase and 7.61 per cent YoY increase.

Its operating profit (EBIT) for the quarter amounted to Rs 229.34 crore and its EBIT margin stood at 14.35 per cent.

The company reported PAT of Rs 149.03 crore, which represents a sequential QoQ increase of 28.35 per cent and a YoY increase of 1272.28 per cent.

Jubilant Life Sciences is Indian integrated pharmaceutical and life sciences company. The company operates in two business segments: pharmaceuticals and life science products and services and agri and performance polymers. The company's product portfolio includes life science ingredients which consists of APIs, proprietary products and exclusive synthesis, nutrition Ingredients, life science chemicals. Its generic products consist of radio pharmaceuticals, allergenic extracts, dosage forms and life science services.